Pharmacy sales in Ukraine for the January–March 2025 period rose by 11.13% in monetary terms compared to the same period in 2025—to more than 60.245 billion UAH, while in volume terms they decreased by 4.8%—to nearly 270,958 thousand packages, the company “Business Credit” reported to the agency “Interfax-Ukraine,” citing data from a study.
According to the data, the weighted average price of the pharmacy basket of goods for January–March 2026 was 222.34 UAH per package, which is 16.78% higher than during the same period a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 13.9% in monetary terms—to more than 48.426 billion UAH—and by 4.85% in volume terms compared to the same period in 2025, reaching nearly 211.947 million packages.
The weighted average retail price of medicines for the first two months of 2026 was 228.49 UAH per package, which is 8.63% higher than in January–March 2025.
At the same time, pharmacy sales of dietary supplements in the first three months of 2026 increased by 14.5% in monetary terms—to nearly 7.03 billion UAH—while sales in volume terms decreased by 14.97%, to 22.378 million packages. The weighted average price in this segment rose by 34.7%—to 314.13 UAH per unit.
As reported, pharmacy sales in Ukraine for 2025 increased by 14.23% in monetary terms compared to 2024—to more than UAH 220.287 billion, while in volume terms they decreased by 2.25%—to nearly 1.135 million packages. The weighted average price of items in the pharmacy basket at the end of 2025 was 194.68 UAH per package, which is 16.86% higher than a year earlier.
At the same time, pharmacy sales of medicines during this period increased by 12.79% in monetary terms—to nearly UAH 170.318 billion—while in volume terms, they decreased by 0.2% compared to 2024, to 808.546 million packages.
The weighted average retail price of medicines at the end of 2025 was 210.65 UAH per package, which is 13% higher than at the end of 2024.
The pharmaceutical company “Farmak” remains the leader in retail sales in 2025 among domestic companies, with sales of nearly 10.978 billion UAH. The top 5 also included the pharmaceutical company “Darnitsa” (7.473 billion UAH), “Kyiv Vitamin Plant” (KVZ, nearly 6.842 billion UAH), ‘Arterium’ (5.975 billion UAH), and “Pharma Star/Acino” (2.9 billion UAH).
Pharmacy sales in Ukraine in April 2025 decreased by 6.7% in monetary terms compared to March of this year, to UAH 16.96 billion, while in real terms they remained at 94.562 million packages, which is 0.41% more than in March.
According to information provided to the Interfax-Ukraine news agency by Business Credit, based on its research, the weighted average price of goods in the pharmacy basket at the end of April was 179.36 UAH, which is 7.1% less than in March.
At the same time, pharmacy sales of medicines in April 2025 amounted to more than UAH 13.071 billion, which is 8% less than in March. In real terms, pharmacy sales of medicines in April decreased by 2.15% compared to March, to 65.742 million packages.
The average retail price of medicines in April was 198.83 UAH per unit, which is 6.09 less than in March.
Pharmacy sales of dietary supplements in April decreased by 6.47% in monetary terms, to UAH 1.952 billion, and by almost 1.74% in real terms, to 8.368 million packages. The average price in this segment at the end of April decreased by 4.82% compared to March, to UAH 232.82 per unit.
At the same time, according to Business Credit, in April, the pharmacy segment saw price increases compared to March for dermatological cosmetics (by 11.9%), cosmetics (by 5.54%), and medical equipment (by 5.74%).
As reported, pharmacy sales in Ukraine at the end of 2024 increased in monetary terms by 10.67% compared to 2023, to UAH 192.843 billion, and in real terms decreased by 5%, to over 1.157 billion packages. The average price of goods in the pharmacy basket at the end of 2024 was UAH 166.59, which is 16.53% more than in 2023.
At the same time, pharmacy sales of medicines in 2024 amounted to UAH 151 billion, which is 10.83% more than a year earlier, but in real terms, pharmacy sales of medicines decreased by 5.64% to 810.155 million packages. The weighted average retail price of medicines at the end of 2024 was UAH 186.39 per unit, which is 17.45% more than in 2023.
Pharmacy sales of dietary supplements in 2024 increased by 11.06% in monetary terms, to UAH 19.992 billion, and decreased by almost 3.06% in real terms, to 99.012 million packages. The weighted average price in this segment at the end of 2024 increased by 14.56% compared to 2023, to UAH 201.92 per unit.
According to the Ministry of Health, as of the end of April, there has been a significant decrease in prices for medicines included in the list of the top 100 most popular medicines and in the additional list of 200 medicines. The retail prices of medicines from the additional list (over 200 Ukrainian medicines) fell by 30%.
In February, Ukrainian President Volodymyr Zelensky enacted the National Security and Defense Council’s decision of February 12 on additional measures to ensure the availability of medicines for Ukrainians. According to this decision, the government, manufacturers, and pharmacy chains will determine a list of 100 drugs for which prices will be reduced by 30% starting March 1. It was also planned to ban marketing and promotional services related to the sale of medicines to end consumers from March 1 until the Cabinet of Ministers introduces separate wholesale price references for all medicines.
By the summer of 2024, the Podorozhnyk pharmacy chain plans to expand its network to 2 thousand pharmacies, said Taras Kolyada, CEO of the chain.
“We currently have 1763 pharmacies. In 2023, we opened 400 new pharmacies. By the summer of 2024, we will grow to 2 thousand pharmacies,” he said in an interview with Forbes.
Mr. Kolyada said that the chain is currently expanding at a fairly rapid pace: “In 2019, we opened 486 pharmacies, and now 400 pharmacies a year is a normal rhythm for us.”
At the same time, he noted that “we usually have 150 outlets in back closer – somewhere we are doing repairs and looking for people, somewhere we are signing a contract or waiting for the lease with the previous owner of the premises to end.”
“Landlords perceive a pharmacy as a stable business and are ready to cooperate. We are building the coverage of the country. For us, the key is to penetrate the regions, small towns from Chop to Seredyna-Buda, from Reni to the north of Chernihiv region,” he said.
In addition, Kolyada said that in 2023, sales of Podorozhnyk across all channels increased by 40-50% compared to 2022.
At the same time, Kolyada predicts that in general, “the trend for network expansion in Ukraine is still there, but the redistribution of the market will favor system operators.”
According to Kolyada, the average investment in opening a pharmacy is up to UAH 3.5 million.
Pharmacy sales in Ukraine in April 2019 in monetary terms rose by 16.1% compared with April 2018, to UAH 8.073 billion, but decreased by 3.7% in natural terms, to 139.8 million packages.
According to the Apteka edition, with reference to data from the analytical system PharmXplorer/Pharmstandard, in April 2019 sales of medicines in monetary terms grew by 14.6% compared to April 2018, to UAH 6.703 billion, in natural terms by 4%, to 88.9 million packs.
The Ukrainian pharmaceutical companies Farmak, the corporations Arterium and Darnitsa, as well as Teva (Israel) and Sanofi (France) are among the top five marketing organizations.
As reported, in 2018 pharmacy sales in Ukraine in monetary terms increased by 23.4% compared with 2017, to UAH 84.574 billion, sales in natural terms for the period decreased by 0.84% compared with 2017, to 1.52 billion packages.
TAS pharmacy chain (TAS Pharma LLC), part of TAS Group, intends to acquire another 60 pharmacies in the near future, increasing their number to 153 by February 2019. According to a press release from the network, TAS has begun a deal to acquire a pharmaceutical network of 26 pharmacies. In addition, negotiations are underway on the acquisition of another 34 pharmacies owned by two participants in the domestic pharmaceutical market.
“The acquisition of 60 pharmacies will allow us to increase our company’s share in the pharmaceutical market of Ukraine, improve its efficiency and strengthen our position in the top 20 pharmacy chains of the country,” the press service said citing director general of the chain Valeriy Hudzenko.
TAS Group was founded in 1998. It has assets in financial and industrial sectors, agriculture, real estate, pharmaceuticals, and venture projects. The financial sector of the group includes TAScombank, Universal Bank, VS Bank, two insurance companies and a number of other organizations. The founder and main shareholder of the group is Sergiy Tigipko.
Pharmacy sales in Ukraine in January-October 2018 in monetary terms increased by 28% compared to the same period in 2017, to UAH 68.665 billion. Business Credit company told Interfax-Ukraine, in natural terms sales for the specified period remained unchanged, being 1.229 million packages, while the weighted average price rose by 28%, to UAH 55.60 per unit of goods.
According to the company, retail sales of medicines in January-October in monetary terms increased by 30%, to UAH 56.732 billion, in natural terms by 9%, to 833.893 million packages. The weighted average price of medicines in January-October 2018 was UAH 68 per product unit.
As reported, in January-September 2018 pharmacy sales in Ukraine in monetary terms were up by 30% compared to the same period in 2017 and amounted to UAH 61.788 billion, while sales in kind by 1%, to 1.124 billion packages.
Retail sales of drugs in January-September 2018 in monetary terms grew by 32%, to UAH 50.805 billion, in natural terms by 10%, to 754.352 million packages.
